Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
Clinical trial NCT00747825 · TERMINATED
Trial details
- NCT number
- NCT00747825
- Sponsor
- Molecular Insight Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.